NCT06898294 Assessment of Kidney Function by Electrical Impedance Tomography (EIT)
| NCT ID | NCT06898294 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The University of Hong Kong |
| Condition | Chronic Kidney Diseases |
| Study Type | OBSERVATIONAL |
| Enrollment | 144 participants |
| Start Date | 2021-09-01 |
| Primary Completion | 2025-08-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 144 participants in total. It began in 2021-09-01 with a primary completion date of 2025-08-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The product under investigation is named Gense EIT-kidney device. This kidney device is a portable and non-invasive imaging modality capable of capturing the cross-sectional bioelectrical impedance distribution of the kidney at multiple current injection frequencies using electrical impedance tomography (EIT). Currently, the kidney device employs a band consisting of 16 equally distributed electrodes around the abdomen. The electrode band is connected to a control unit that switches the electrode stimulation and measurement pairs, then sends the collected measurement to a computational unit for image reconstruction. The images are then post-processed to extract functional kidney images for diagnosis. This kidney device can connect to an external screen, allowing the functional images to be produced and visualized.
Eligibility Criteria
Inclusion Criteria: \- clinically diagnosed with CKD at different stages (stage 1-5) of the disease based on GFR measurement results Age: 18-90. Gender: Male/ Female Exclusion Criteria: * ● Subjects with known kidney disease or abnormalities (for the control group). * Subjects who had any kind of kidney surgery or kidney transplantation. * Subjects with damaged skin on the abdomen. * Subjects with implanted electronic devices. * Subjects with spinal diseases/discomfort * Subjects who had any recent abdominal surgery * Pregnant women. * Obese subjects (BMI\>35). * Subjects with uncontrollable involuntary body movements such as degenerative disorders (e.g., Alzheimer's and Parkinson's disease); Seizure disorders (e.g., epilepsy, stroke, neuroleptic drugs); Neurological disorders (e.g., tardive dyskinesia and cerebral palsy, tremors, myoclonus, tics, athetosis, etc.)
Contact & Investigator
Yat Hin, Desmond Yap, PhD, MD
PRINCIPAL INVESTIGATOR
The University of Hong Kong
Frequently Asked Questions
Who can join the NCT06898294 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 90 Years, studying Chronic Kidney Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06898294 currently recruiting?
Yes, NCT06898294 is actively recruiting participants. Contact the research team at desmondy@hku.hk for enrollment information.
Where is the NCT06898294 trial being conducted?
This trial is being conducted at Hong Kong, Hong Kong.
Who is sponsoring the NCT06898294 clinical trial?
NCT06898294 is sponsored by The University of Hong Kong. The principal investigator is Yat Hin, Desmond Yap, PhD, MD at The University of Hong Kong. The trial plans to enroll 144 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.